119 related articles for article (PubMed ID: 1009035)
1. Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss.
Hahn L; Cederblad G; Rybo G; Pehrsson NG; Bengtsen KK
Br J Obstet Gynaecol; 1976 Dec; 83(12):974-80. PubMed ID: 1009035
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.
Hahn L; Rybo G
Acta Obstet Gynecol Scand; 1975; 54(2):119-27. PubMed ID: 1136717
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
[TBL] [Abstract][Full Text] [Related]
4. Fibrin degradation products in sera of women with normal menstruation and menorrhagia.
Basu HK
Br Med J; 1970 Jan; 1(5688):74-5. PubMed ID: 5411448
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
[TBL] [Abstract][Full Text] [Related]
6. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.
Edlund M; Blombäck M; He S
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):593-8. PubMed ID: 12960614
[TBL] [Abstract][Full Text] [Related]
7. Menstrual blood loss and fibrin degradation products.
Cole SK; Clarkson AR
Br Med J; 1972 Jan; 1(5792):78-9. PubMed ID: 5007072
[TBL] [Abstract][Full Text] [Related]
8. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle.
Cederblad G; Hahn L; Korsan-Bengtsen K; Pehrsson NG; Rybo G
Haemostasis; 1977; 6(5):294-302. PubMed ID: 598750
[TBL] [Abstract][Full Text] [Related]
9. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].
Mutoh S; Teh A; Shimoji Y; Nishi N; Saitoh M; Maki M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2049-58. PubMed ID: 3878385
[TBL] [Abstract][Full Text] [Related]
10. Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses.
Napolitano M; Dolce A; Celenza G; Grandone E; Perilli MG; Siragusa S; Carta G; Orecchioni A; Mariani G
Ann Hematol; 2014 Apr; 93(4):557-63. PubMed ID: 24048634
[TBL] [Abstract][Full Text] [Related]
11. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in idiopathic menorrhagia.
Bisht D; Gupta SC; Kaushik S; Ganguli G; Mital VP
Indian J Pathol Microbiol; 1991 Jul; 34(3):200-2. PubMed ID: 1818856
[TBL] [Abstract][Full Text] [Related]
14. Aqueous extract from Brownea grandiceps flowers with effect on coagulation and fibrinolytic system.
Pereira B; Brazón J
J Ethnopharmacol; 2015 Feb; 160():6-13. PubMed ID: 25460592
[TBL] [Abstract][Full Text] [Related]
15. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Milsom I; Andersson K; Andersch B; Rybo G
Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
[TBL] [Abstract][Full Text] [Related]
16. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
17. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
Jespersen J
Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
[TBL] [Abstract][Full Text] [Related]
18. Coagulation factors and fibrinolytic proteins in menstrual fluid collected from normal and menorrhagic women.
Rees MC; Cederholm-Williams SA; Turnbull AC
Br J Obstet Gynaecol; 1985 Nov; 92(11):1164-8. PubMed ID: 2415154
[TBL] [Abstract][Full Text] [Related]
19. On fibrinolysis and coagulation during parturition and menstruation.
Hahn L
Acta Obstet Gynecol Scand Suppl; 1974; 28():7-40. PubMed ID: 4599650
[No Abstract] [Full Text] [Related]
20. Blood coagulation and fibrinolytic factors in 105 patients with hemorrhagic syndrome caused by accidental contact with Lonomia obliqua caterpillar in Santa Catarina, southern Brazil.
Zannin M; Lourenço DM; Motta G; Dalla Costa LR; Grando M; Gamborgi GP; Noguti MA; Chudzinski-Tavassi AM
Thromb Haemost; 2003 Feb; 89(2):355-64. PubMed ID: 12574817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
